Shares of 4d Pharma PLC (LON: DDDD) today fell 7.32% due to the lack of positive fundamental drivers to boost the biotech company’s share price as the UK, European and global stocks markets sold off.
The firm’s shares have sold off this week reversing most of the gains made last week after announcing that it was merging with Longevity Acquisition Corporation (NASDAQ: LOAC) (“Longevity”), a NASDAQ-listed Special Purpose Acquisition Company (“SPAC”), to gain access to US markets.
The deal is worth up to $37.6 million to 4D pharma and will see the firm launch a new NASDAQ-listed American Depositary Share (ADS) programme under the ticker symbol ‘LBPS’ and be immediately admitted to trading on NASDAQ upon completion.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Despite the latest downtrend 4D Pharma is still a solid company given that it holds over 1000 patents and is a leader in the microbiome industry and could present an excellent investment opportunity to the right investor.
The firm has multiple projects at various stages of development with significant potential given its cutting edge technology used in its MicroRx platform, hence, its long-term prospects remain very attractive.
4D Pharma share price
4D Pharma shares today fell 7.32% to trade at 107.5p having dropped from Tuesday’s closing price of 116p.
People who read this also read:
